Indonesia’s Ambitious Plan to Turn the Tide Against Tuberculosis
Indonesia is embarking on a critical phase in its fight against tuberculosis (TB), a disease that continues to claim thousands of lives annually. Despite strong political commitment, the nation faces a persistently high TB burden, with over 1 million cases estimated in 2023 and approximately 130,927 deaths. A new National Strategic Plan for Tuberculosis 2026–2030, developed with support from the World Health Organization (WHO) and other partners, aims to dramatically alter this trajectory.
Understanding the Scale of the Challenge
Globally, Indonesia holds the second-highest TB burden, trailing only India. Between 2015 and 2023, the estimated incidence of TB in Indonesia actually increased by 19%, with deaths rising by 26%. This underscores the complex challenges the country faces, including underreporting, particularly within the private sector, and systemic gaps in the national TB program.
The recent August 2025 National TB Programme Review, combined with an epidemiological review, pinpointed key areas for improvement. These include strengthening people-centred services and bolstering health system support. The reviews involved extensive consultations with stakeholders – government agencies, civil society, professional associations, affected communities, and development partners – to identify priority gaps and clarify roles.
The 2026-2030 Strategic Plan: A People-Centred Approach
The upcoming National Strategic Plan is built on an evidence-based framework and collaborative partnerships. It aims to prioritize interventions with the greatest impact, align investments, and strengthen coordination across all levels of the healthcare system. A key goal is to identify and link one million people with TB to care within the next year, achieving a treatment success rate of 90%.
A significant focus will be on updating the 2021 Presidential Decree on TB. This revision is expected to strengthen legal authority and secure sustainable financing for the national program. Preventive treatment remains a challenge, but there is optimism surrounding the potential introduction of a TB vaccine by the conclude of 2028 or early 2029.
Innovation and Future Directions
Indonesia is similarly exploring regulatory and financing reforms to support TB elimination. The country recognizes the need to address programmatic bottlenecks that have hindered progress in the past. The plan emphasizes a people-centred approach, ensuring that services are accessible and responsive to the needs of those affected by TB.
Did you know? Indonesia’s fight against TB is supported by organizations like the Gates Foundation and the Global Fund, highlighting the international commitment to eradicating this disease.
Addressing Underreporting and Improving Surveillance
A critical barrier to effective TB control in Indonesia is underreporting. Improving surveillance systems, particularly within the private healthcare sector, is essential to accurately track the disease’s spread and ensure that all cases receive appropriate treatment. This will require strengthening collaboration between public and private healthcare providers.
FAQ: Tuberculosis in Indonesia
Q: What is Indonesia’s target for TB elimination?
A: Indonesia aims to eliminate TB by 2030.
Q: How many TB cases were estimated in Indonesia in 2023?
A: Approximately 1.09 million cases were estimated in 2023.
Q: What is the focus of the new National Strategic Plan?
A: The plan focuses on improving case detection, treatment success rates, and strengthening the overall TB response through a people-centred approach.
Q: Is a TB vaccine expected in Indonesia?
A: There is hope for a TB vaccine to be introduced by the end of 2028 or early 2029.
Pro Tip: Early detection is crucial for successful TB treatment. If you experience symptoms such as a persistent cough, fever, night sweats, or weight loss, seek medical attention immediately.
Learn more about global efforts to end TB at the World Health Organization’s Global Tuberculosis Programme.
What are your thoughts on Indonesia’s new TB strategy? Share your comments below and join the conversation!
